sotrovimab
Trade name: Xevudy
mAbexperimentalCOVID-19
Clinical trial activity
12 trials · 13 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
6
Phase 3
3
Phase 4
2
Earliest trial started Feb 12, 2021 (NCT04748588)
Timeline
Indications
Approved for
Mechanism of action
- Spike glycoproteinANTAGONIST
Spike glycoprotein antagonist
- Spike glycoproteinINHIBITOR
Spike glycoprotein inhibitor
Receptor-binding domain
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4650524 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05305651 | Phase 4 | Jul 1, 2022 | GlaxoSmithKline |
| NCT05135650 | Phase 1 | May 1, 2022 | National Marrow Donor Program, University of Washington, Vir Biotechnology, Inc. |
| NCT05280717 | Phase 1 | Mar 28, 2022 | GlaxoSmithKline, Vir Biotechnology, Inc. |
| NCT05321394 | Phase 3 | Mar 7, 2022 | Agenzia Italiana del Farmaco, University of Udine, University of Verona |
| NCT05210101 | Phase 2 | Jan 31, 2022 | GlaxoSmithKline, Harvard University |
| NCT05205759 | Phase 3 | Dec 9, 2021 | Agenzia Italiana del Farmaco, University of Udine, University of Verona |
| NCT05124210 | Phase 2 | Dec 3, 2021 | GlaxoSmithKline, Vir Biotechnology, Inc. |
| NCT04988152 | Phase 1 | Jul 6, 2021 | GlaxoSmithKline, Vir Biotechnology, Inc. |
| NCT04790786 | Phase 3 | Mar 10, 2021 | Berry Consultants, University of Pittsburgh |
| NCT04779879 | Phase 2 | Feb 18, 2021 | GlaxoSmithKline, Vir Biotechnology, Inc. |
| NCT04748588 | Phase 4 | Feb 12, 2021 | University of British Columbia, University of Calgary, University of Toronto |
| NCT05235347 | N/A | — | Vir Biotechnology, Inc. |
Showing 12 of 12 trials
Page 1 / 1
Organizations
Research & Development (13)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 6 | 2 | 3 | 2021 |
| Vir Biotechnology, Inc. | For profit | 6 | 4 | 3 | 2021 |
| Agenzia Italiana del Farmaco | Government | 2 | 0 | 1 | 2021 |
| University of Udine | Academic/Hospital | 2 | 0 | 1 | 2021 |
| University of Verona | Academic/Hospital | 2 | 2 | 1 | 2021 |
| Berry Consultants | For profit | 1 | 0 | 1 | 2021 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| National Marrow Donor Program | Government | 1 | 0 | 1 | 2022 |
| University of British Columbia | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Calgary | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Pittsburgh | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Toronto | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Washington | Academic/Hospital | 1 | 1 | 1 | 2022 |
13 organizations
Page 1 / 1